VLT-015 in Patients With Schizophrenia
NCT05516121
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
VLT-015
Sponsor
CF Pharma, LLC